Bank of America Lowers PTC Therapeutics (NASDAQ:PTCT) Price Target to $93.00
PTC Therapeutics (NASDAQ:PTCT – Get Free Report) had its price target cut by research analysts at Bank of America from $97.00 to $93.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. Bank of America‘s price target points to a potential upside [...]



